Pregnancy and Systemic Lupus Erythematosus

Handbook of Systemic Autoimmune Diseases

Volumn 4, Issue , 2005, Pages 43-57

  Clowse, Megan E B ^a   Petri, Michelle ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 47349098645     PISSN: 15715078     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1571-5078(05)04005-5     Document Type: Review

References (65)

1. Abramowsky C.R. Lupus erythematosus, the placenta, and pregnancy: a natural experiment in immunologically mediated reproductive failure. Prog. Clin. Biol. Res. 70 (1981) 309-320
2. Abramson S.B., and Buyon J.P. Activation of the complement pathway: comparison of normal pregnancy, preeclampsia, and systemic lupus erythematosus during pregnancy. Am. J. Reprod. Immunol. 28 (1992) 183-187
3. Bobrie G., Liote F., Houillier P., Grunfeld J.P., and Jungers P. Pregnancy in lupus nephritis and related disorders. Am. J. Kidney Dis. 9 (1987) 339-343
4. Branch, D.W. 2004. Pregnancy in patients with rheumatic diseases: obstetric management and monitoring. Lupus 13, 696-698. A current review of obstetrical management for women with lupus, rheumatoid arthritis, scleroderma, and antiphospholipid antibody syndrome.
5. Buchanan N.M., Khamashta M.A., Morton K.E., Kerslake S., Baguley E.A., and Hughes G.R. A study of 100 high risk lupus pregnancies. Am. J. Reprod. Immunol. 28 (1992) 192-194
6. Buyon, J.P., Kalunian, K.C., Ramsey-Goldman, R., Petri, M.A., Lockshin, M.D., Ruiz-Irastorza, G., Khamashta, M. 1999. Assessing disease activity in SLE patients during pregnancy. Lupus 8, 677-684. A review of the signs and symptoms of pregnancy that can mimic lupus activity. Outlines several instruments to measure lupus activity during pregnancy.
7. Carmona, F., Font, J., Cervera, R., Munoz, F., Cararach, V., Balasch, J. 1999. Obstetrical outcome of pregnancy in patients with systemic Lupus erythematosus. A study of 60 cases. Eur. J. Obstet. Gynecol. Reprod. Biol. 83, 137-142. A prospective study of 60 pregnancies in lupus patients. The majority of the patients had inactive lupus at conception, leading to good pregnancy outcomes.
8. Clark, C.A., Spitzer, K.A., Nadler, J.N., Laskin, C.A. 2003. Preterm deliveries in women with systemic lupus erythematosus, J. Rheumatol. 30, 2127-2132. A comparison of lupus pregnancies that resulted in preterm versus fullterm deliveries that identifies multiple risk factors for preterm delivery.
9. Clowse M., Magder L.C., and Petri M. Impact of the intensity and timing of lupus activity on pregnancy outcomes [abstract #1085]. Arthritis Rheum. 48 (2003) S435
10. Clowse M., Magder L.C., and Petri M. The effect of hydroxychloroquine on pregnancy outcomes and disease activity in lupus patients [abstract #1846]. Arthritis Rheum. 50 (2004)
11. Clowse M.E., Magder L., and Petri M. Cyclophosphamide for lupus during pregnancy. Lupus 14 (2005) 593-597
12. Clowse, M., Witter, F. R., Magder, L. C., Petri, M. 2005. The impact of increased lupus activity on obstetrical outcomes. Arthritis Rheum. 52, 514-521. A report of 267 pregnancies in lupus patients in the Hopkins Lupus Pregnancy Cohort from 1987 to 2002.
13. Cortes-Hernandez, J., Ordi-Ros, J., Paredes, F., Casellas, M., Castillo, F., Vilardell-Tarres, M. 2002. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford) 41, 643-650. A prospective cohort study of 103 pregnancies in lupus patients that identifies risk factors for fetal loss, prematurity, and intrauterine growth restriction.
14. Costedoat-Chalumeau N., Amoura Z., Duhaut P., Huong du L.T., Sebbough D., Wechsler B., Vauthier D., Denjoy I., Lupoglazoff J.M., and Piette J.C. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum. 48 (2003) 3207-3211
15. Di Simone N., Meroni P.L., de Papa N., et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arithritis Rheum. 43 (2000) 140-150
16. Druzin M.L., Lockshin M., Edersheim T.G., Hutson J.M., Krauss A.L., and Kogut E. Second-trimester fetal monitoring and preterm delivery in pregnancies with systemic lupus erythematosus and/or circulating anticoagulant. Am. J. Obstet. Gynecol. 157 (1987) 1503-1510
17. Fraga A., Mintz G., Orozco J., and Orozco J. Sterility and fertility rates, fetal wastage and maternal morbidity in systemic lupus erythematosus. J. Rheumatol. 1 (1974) 293-298
18. Georgiou P.E., Politi E.N., Katsimbri P., Sakka V., and Drosos A.A. Outcome of lupus pregnancy: a controlled study. Rheumatology (Oxford) 39 (2000) 1014-1019
19. Gordon, M.C. 2002. Maternal Physiology in Pregnancy. In: S.G. Gabbe (Ed.), Obstetrics: Normal and Problem Pregnancies, fourth edition, Chapter 3. Churchill Livingstone, New York.
20. Gregg A.R. Hypertension in pregnancy. Obstet. Gynecol. Clin. N. Am. 31 (2004) 223-241 v
21. Grennan D.M., McCormick J.N., Wojtacha D., Carty M., and Behan W. Immunological studies of the placenta in systemic lupus erythematosus. Ann. Rheum. Dis. 37 (1978) 129-134
22. Haeger M., Unander M., and Bengtsson A. Enhanced anaphylatoxin and terminal C5b-9 complement complex formation in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet. Gynecol. 76 (1990) 698-702
23. Hardy C.J., Palmer B.P., Morton S.J., Muir K.R., and Powell R.J. Pregnancy outcome and family size in systemic lupus erythematosus: a case-control study. Rheumatology (Oxford) 38 (1999) 559-563
24. Janssen N.M., and Genta M.S. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch. Intern. Med. 160 (2000) 610-619
25. Johnson M.J., Petri M., Witter F.R., and Repke J.T. Evaluation of preterm delivery in a systemic lupus erythematosus pregnancy clinic. Obstet. Gynecol. 86 (1995) 396-399
26. Julkunen H. Pregnancy and lupus nephritis. Scand. J. Urol. Nephrol. 35 (2001) 319-327
27. Jungers P., Dougados M., Pelissier C., Kuttenn F., Tron F., Lesavre P., and Bach J.F. Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients. Arch. Intern. Med. 142 (1982) 771-776
28. Karim M.Y., Ruiz-Irastorza G., Khamashta M.A., and Hughes G.R. Update on therapy-thalidomide in the treatment of lupus. Lupus 10 (2001) 188-192
29. Kart Koseoglu H., Yucel A.E., Kunefeci G., Ozdemir F.N., and Duran H. Cyclophosphamide therapy in a serious case of lupus nephritis during pregnancy. Lupus 10 (2001) 818-820
30. Katz J.A., and Pore G. Inflammatory bowel disease and pregnancy. Inflamm. Bowel. Dis. 7 (2001) 146-157
31. Kiss E., Bhattoa H.P., Bettembuk P., Balogh A., and Szegedi G. Pregnancy in women with systemic lupus erythematosus. Eur. J. Obstet. Gynecol. Reprod. Biol. 101 (2002) 129-134
32. Klinger G., Morad Y., Westall C.A., Laskin C., Spitzer K.A., Koren G., Ito S., and Buncic R.J. Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases. Lancet 358 (2001) 813-814
33. Levy, R.A., Vilela, V.S., Cataldo, M.J., Ramos, R.C., Duarte, J.L., Tura, B.R., Albuquerque, E.M., Jesus, N.R. 2001. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 10, 401-404. A randomized trial of hydroxychloroquine use in pregnancy that shows improvement in lupus activity and pregnancy outcomes with the medication.
34. Lima F., Buchanan N.M., Khamashta M.A., Kerslake S., and Hughes G.R. Obstetric outcome in systemic lupus erythematosus. Semin. Arthritis Rheum. 25 (1995) 184-192
35. Lockshin M.D. Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum. 32 (1989) 665-670
36. Lockshin M.D., Reinitz E., Druzin M.L., Murrman M., and Estes D. Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am. J. Med. 77 (1984) 893-898
37. Magid M.S., Kaplan C., Sammaritano L.R., Peterson M., Druzin M.L., and Lockshin M.D. Placental pathology in systemic lupus erythematosus: a prospective study. Am. J. Obstet. Gynecol. 179 (1998) 226-234
38. Martinez-Rueda J.O., Arce-Salinas C.A., Kraus A., Alcocer-Varela J., and Alarcon-Segovia D. Factors associated with fetal losses in severe systemic lupus erythematosus. Lupus 5 (1996) 113-119
39. Moroni G., and Ponticelli C. The risk of pregnancy in patients with lupus nephritis. J. Nephrol. 16 (2003) 161-167
40. Motta M., Tincani A., Faden D., Zinzini E., and Chirico G. Antimalarial agents in pregnancy. Lancet 359 (2002) 524-525
41. Petri M. Hopkins lupus pregnancy center: 1987 to 1996. Rheum. Dis. Clin. N. Am. 23 (1997) 1-13
42. Petri M. Immunosuppressive drug use in pregnancy. Autoimmunity 36 (2003) 51-56
43. Petri, M., Allbritton, J. 1993. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort. J. Rheumatol. 20, 650-656. A comparison of pregnancy rates and outcomes in a large number of women with lupus versus their healthy friends and relatives.
44. Petri M., Ho A.C., Patel J., Demers D., Joseph J.M., and Goldman D. Elevation of maternal alpha-fetoprotein in systemic lupus erythematosus: a controlled study. J. Rheumatol. 22 (1995) 1365-1368
45. Petri M., Howard D., and Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum. 34 (1991) 1538-1545
46. Petri M., Howard D., Repke J., and Goldman D.W. The Hopkins Lupus Pregnancy Center: 1987-1991 update. Am. J. Reprod. Immunol. 28 (1992) 188-191
47. Ramsey-Goldman, R., Mientus, J.M., Kutzer, J.E., Mulvihill, J.J., Medsger, T.A., Jr. 1993. Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs. J. Rheumatol. 20, 1152-1157. A retrospective study of the impact of the prior use of immunosuppressive drugs on pregnancy outcomes.
48. Ramsey-Goldman R., and Schilling E. Immunosuppressive drug use during pregnancy. Rheum. Dis. Clin. N. Am. 23 (1997) 149-167
49. Rubbert A., Pirner K., Wildt L., Kalden J.R., and Manger B. Pregnancy course and complications in patients with systemic lupus erythematosus. Am. J. Reprod. Immunol. 28 (1992) 205-207
50. Ruiz-Irastorza G., Lima F., Alves J., Khamashta M.A., Simpson J., Hughes G.R., and Buchanan N.M. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br. J. Rheumatol. 35 (1996) 133-138
51. Salafia C.M., and Parke A.L. Placental pathology in systemic lupus erythematosus and phospholipid antibody syndrome. Rheum. Dis. Clin. N. Am. 23 (1997) 85-97
52. Samuels, P. 2002. Hematologic Complications of Pregnancy. In: S.G. Gabbe (Ed.), Obstetrics: Normal and Problem Pregnancies, fourth edition, Chapter 34. Churchill Livingstone, New York.
53. Schroeder B.M. ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. American College of Obstetricians and Gynecologists. Am. Fam. Physician 66 (2002) 330-331
54. Steen V.D. Pregnancy in women with systemic sclerosis. Obstet. Gynecol. 94 (1999) 15-20
55. Steen V.D., Conte C., Day N., Ramsey-Goldman R., and Medsger Jr. T.A. Pregnancy in women with systemic sclerosis. Arthritis Rheum. 32 (1989) 151-157
56. Taufield P.A., Ales K.L., Resnick L.M., Druzin M.L., Gertner J.M., and Laragh J.H. Hypocalciuria in preeclampsia. N. Eng. J. Med. 316 (1987) 715-718
57. Tincani A., Faden D., Tarantini M., Lojacono A., Tanzi P., Gastaldi A., Di Mario C., Spatola L., Cattaneo R., and Balestrieri G. Systemic lupus erythematosus and pregnancy: a prospective study. Clin. Exp. Rheumatol. 10 (1992) 439-446
58. Tossounian S., and Petri M. Maternal morbidity of SLE pregnancy: a case-control study [abstract]. Arthritis Rheum. 37 (1994) S216
59. Tsakonas E., Joseph L., Esdaile J.M., Choquette D., Senecal J.L., Cividino A., Danoff D., Osterland C.K., Yeadon C., and Smith C.D. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. Lupus 7 (1998) 80-85
60. Urowitz, M.B., Gladman, D.D., Farewell, V.T., Stewart, J., McDonald, J. 1993. Lupus and pregnancy studies. Arthritis Rheum. 36, 1392-1397. A case-control study of pregnant versus non-pregnant lupus patients. Assesses the risk of lupus flare during pregnancy and the importance of pre-pregnancy disease activity.
61. Varner M.W., Meehan R.T., Syrop C.H., Strottmann M.P., and Goplerud C.P. Pregnancy in patients with systemic lupus erythematosus. Am. J. Obstet. Gynecol. 145 (1983) 1025-1040
62. Witter F.R., and Petri M. Antenatal detection of intrauterine growth restriction in patients with systemic lupus erythematosus. Int. J. Gynaecol. Obstet. 71 (2000) 67-68
63. Wolfberg A.J., Lee-Parritz A., Peller A.J., and Lieberman E.S. Association of rheumatologic disease with preeclampsia. Obstet. Gynecol. 103 (2004) 1190-1193
64. Wong K.L., Chan F.Y., and Lee C.P. Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch. Intern. Med. 151 (1991) 269-273
65. Yasmeen, S., Wilkins, E.E., Field, N.T., Sheikh, R.A., Gilbert, W.M. 2001. Pregnancy outcomes in women with systemic lupus erythematosus. J. Matern. Fetal. Med. 10, 91-96. A population study of all deliveries in California in the mid 1990's. A comparison of pregnancy complications and outcomes in women with lupus versus healthy controls.